RYVLX
Price
$685.59
Change
+$7.59 (+1.12%)
Updated
Nov 19 closing price
Net Assets
1.43B
UGPSX
Price
$24.40
Change
-$0.85 (-3.37%)
Updated
Nov 19 closing price
Net Assets
27.96M
Interact to see
Advertisement

RYVLX vs UGPSX

Header iconRYVLX vs UGPSX Comparison
Open Charts RYVLX vs UGPSXBanner chart's image
Rydex NASDAQ-100® 2x Strategy A
Price$685.59
Change+$7.59 (+1.12%)
VolumeN/A
Net Assets1.43B
ProFunds UltraChina Service
Price$24.40
Change-$0.85 (-3.37%)
VolumeN/A
Net Assets27.96M
RYVLX vs UGPSX Comparison Chart in %
View a ticker or compare two or three
VS
RYVLX vs. UGPSX commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RYVLX is a Hold and UGPSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RYVLX has more cash in the bank: 1.43B vs. UGPSX (28M). UGPSX pays higher dividends than RYVLX: UGPSX (1.16) vs RYVLX (0.00). RYVLX was incepted earlier than UGPSX: RYVLX (21 years) vs UGPSX (18 years). UGPSX (2.80) is less costly to investors than RYVLX (1.87). RYVLX is a more actively managed with annual turnover of: 383.00 vs. UGPSX (159.00). RYVLX has a lower initial minimum investment than UGPSX: RYVLX (2500) vs UGPSX (15000). UGPSX annual gain was more profitable for investors over the last year : 38.17 vs. RYVLX (19.37). RYVLX return over 5 years is better than : 118.69 vs. UGPSX (-87.78).
RYVLXUGPSXRYVLX / UGPSX
Total Expense Ratio1.742.8062%
Annual Report Gross Expense Ratio1.872.8067%
Fund Existence21 years18 years-
Gain YTD23.14548.61748%
Front Load5%N/A-
Min. Initial Investment25001500017%
Min. Initial Investment IRAN/AN/A-
Net Assets1.43B28M5,100%
Annual Yield % from dividends0.001.16-
Returns for 1 year19.3738.1751%
Returns for 3 years210.1623.21906%
Returns for 5 years118.69-87.78-135%
Returns for 10 years702.56-74.44-944%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GTHP0.250.01
+2.08%
Guided Therapeutics, Inc.
NCLTY8.340.02
+0.24%
Nitori Holdings Co., Ltd.
EXSPF1.65N/A
N/A
EXPERT AI SPA
DESLF358757760.00N/A
N/A
Descente, Ltd.
CDAUF10.18N/A
N/A
Compass Digital Acquisition Corp.